Human lung mononuclear phagocytes in health and disease

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Baharom, Faezzah ^a   Rankin, Gregory ^b   Blomberg, Anders ^b   Smed Sörensen, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Bronchial tissue; Bronchoalveolar lavage; Dendritic cells; Lung tissue; Macrophages; Monocytes; Pulmonary; Respiratory

Indexed keywords

CELL SURFACE MARKER;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DENDRITIC CELL; FIBROSING ALVEOLITIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG DISEASE; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; LUNG SARCOIDOSIS; MACROPHAGE; MONOCYTE; MONONUCLEAR PHAGOCYTE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; RESPIRATORY TRACT INFECTION; REVIEW; T LYMPHOCYTE;

EID: 85021647535     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00499     Document Type: Review

References (211)

1. World Health Organization. The Top 10 Causes of Death - Fact Sheet No. 310 2014. (2016) Available from: http://www.who.int/mediacentre/factsheets/fs310/en/
2. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol (1978) 32(2):121-40. doi: 10.1016/0034-5687(78)90104-4
3. Green GM, Kass EH. The role of the alveolar macrophage in the clearance of bacteria from the lung. J Exp Med (1964) 119:167-76. doi:10.1084/jem.119.1.167
4. Holt PG, Schon-Hegrad MA, Oliver J. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J Exp Med (1988) 167(2):262-74. doi:10.1084/jem.167.2.262
5. Jakubzick C, Gautier EL, Gibbings SL, Sojka DK, Schlitzer A, Johnson TE, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity (2013) 39(3):599-610. doi:10.1016/j.immuni.2013.08.007
6. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med (1991) 173(6):1345-56. doi:10.1084/jem.173.6.1345
7. Sertl K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA, Shevach EM. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med (1986) 163(2):436-51. doi:10.1084/jem.163.2.436
8. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med (2005) 172(5):530-51. doi:10.1164/rccm.200410-1384SO
9. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol (2011) 11(11):762-74. doi:10.1038/nri3070
10. GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol (2008) 1(6):442-50. doi:10.1038/mi.2008.39
11. Plantinga M, Hammad H, Lambrecht BN. Origin and functional specializations of DC subsets in the lung. Eur J Immunol (2010) 40(8):2112-8. doi:10.1002/eji.201040562
12. Tamoutounour S, Guilliams M, Montanana Sanchis F, Liu H, Terhorst D, Malosse C, et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity (2013) 39(5):925-38. doi:10.1016/j.immuni.2013.10.004
13. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature (1998) 392(6673):245-52. doi:10.1038/32588
14. Blank F, von Garnier C, Obregon C, Rothen-Rutishauser B, Gehr P, Nicod L. Role of dendritic cells in the lung: in vitro models, animal models and human studies. Expert Rev Respir Med (2008) 2(2):215-33. doi:10.1586/17476348.2.2.215
15. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med (2001) 193(1):51-60. doi:10.1084/jem.193.1.51
16. Helft J, Manicassamy B, Guermonprez P, Hashimoto D, Silvin A, Agudo J, et al. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J Clin Invest (2012) 122(11):4037-47. doi:10.1172/JCI60659
17. Mikhak Z, Strassner JP, Luster AD. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J Exp Med (2013) 210(9):1855-69. doi:10.1084/jem.20130091
18. Lambrecht BN. Allergen uptake and presentation by dendritic cells. Curr Opin Allergy Clin Immunol (2001) 1(1):51-9. doi:10.1097/00130832-200102000-00010
19. Immunity in the tissues. Nat Immunol (2013) 14(10):977. doi:10.1038/ni.2722
20. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol (2013) 14(10):986-95. doi:10.1038/ni.2705
21. Heath WR, Carbone FR. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol (2013) 14(10):978-85. doi:10.1038/ni.2680
22. Yewdell JW. Designing CD8+ T cell vaccines: it's not rocket science (yet). Curr Opin Immunol (2010) 22(3):402-10. doi:10.1016/j.coi.2010.04.002
23. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 12(4):265-77. doi:10.1038/nrc3258
24. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 10(5):475-80. doi:10.1038/nm1039
25. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 128(3):415-35. doi:10.1084/jem.128.3.415
26. van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 46(6):845-52.
27. Yona S, Gordon S. From the reticuloendothelial to mononuclear phagocyte system - the unaccounted years. Front Immunol (2015) 6:328. doi:10.3389/fimmu.2015.00328
28. Metchnikoff E, Binnie FG. Immunity in Infective Diseases. Cambridge: University Press (1905). xvi, 591 p.
29. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 137(5):1142-62. doi:10.1084/jem.137.5.1142
30. Steinman RM, Kaplan G, Witmer MD, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med (1979) 149(1):1-16. doi:10.1084/jem.149.1.1
31. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med (1974) 139(2):380-97. doi:10.1084/jem.139.6.1431
32. Steinman RM, Adams JC, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med (1975) 141(4):804-20.
33. Cohn ZA, Benson B. The differentiation of mononuclear phagocytes. Morphology, cytochemistry, and biochemistry. J Exp Med (1965) 121:153-70. doi:10.1084/jem.121.1.153
34. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol (1998) 160(9):4587-95.
35. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med (1994) 179(4):1109-18. doi:10.1084/jem.179.4.1109
36. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 176(6):1693-702. doi:10.1084/jem.176.6.1693
37. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 184(2):695-706. doi:10.1084/jem.184.2.695
38. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity (1999) 11(6):753-61. doi:10.1016/S1074-7613(00)80149-1
39. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19(1):71-82. doi:10.1016/S1074-7613(03)00174-2
40. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity (2003) 19(1):59-70. doi:10.1016/S1074-7613(03)00171-7
41. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, Margalit R, et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med (2007) 204(1):171-80. doi:10.1084/jem.20061011
42. Naik SH, Sathe P, Park HY, Metcalf D, Proietto AI, Dakic A, et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol (2007) 8(11):1217-26. doi:10.1038/ni1522
43. Onai N, Obata-Onai A, Schmid MA, Ohteki T, Jarrossay D, Manz MG. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol (2007) 8(11):1207-16. doi:10.1038/ni1518
44. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 31:563-604. doi:10.1146/annurev-immunol-020711-074950
45. D'Amico A, Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med (2003) 198(2):293-303. doi:10.1084/jem.20030107
46. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med (2003) 198(2):305-13. doi:10.1084/jem.20030323
47. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko AC, Krijgsveld J, et al. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol (2013) 14(8):821-30. doi:10.1038/ni.2638
48. Breton G, Lee J, Zhou YJ, Schreiber JJ, Keler T, Puhr S, et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells. J Exp Med (2015) 212(3):401-13. doi:10.1084/jem.20141441
49. Lee J, Breton G, Oliveira TY, Zhou YJ, Aljoufi A, Puhr S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med (2015) 212(3):385-99. doi:10.1084/jem.20141442
50. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 330(6005):841-5. doi:10.1126/science.1194637
51. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 336(6077):86-90. doi:10.1126/science.1219179
52. Guilliams M, De Kleer I, Henri S, Post S, Vanhoutte L, De Prijck S, et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med (2013) 210(10):1977-92. doi:10.1084/jem.20131199
53. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity (2013) 38(4):792-804. doi:10.1016/j.immuni.2013.04.004
54. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity (2013) 38(1):79-91. doi:10.1016/j.immuni.2012.12.001
55. Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature (2015) 518(7540):547-51. doi:10.1038/nature13989
56. van de Laar L, Saelens W, De Prijck S, Martens L, Scott CL, Van Isterdael G, et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity (2016) 44(4):755-68. doi:10.1016/j.immuni.2016.02.017
57. Guilliams M, van de Laar L. A Hitchhiker's guide to myeloid cell subsets: practical implementation of a novel mononuclear phagocyte classification system. Front Immunol (2015) 6:406. doi:10.3389/fimmu.2015.00406
58. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol (2014) 14(8):571-8. doi:10.1038/nri3712
59. Boltjes A, van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol (2014) 5:131. doi:10.3389/fimmu.2014.00131
60. Fernandez FG, Kosinski AS, Burfeind W, Park B, DeCamp MM, Seder C, et al. The society of thoracic surgeons lung cancer resection risk model: higher quality data and superior outcomes. Ann Thorac Surg (2016) 102(2):370-7. doi:10.1016/j.athoracsur.2016.02.098
61. Ojo AO, Heinrichs D, Emond JC, McGowan JJ, Guidinger MK, Delmonico FL, et al. Organ donation and utilization in the USA. Am J Transplant (2004) 4(Suppl 9):27-37. doi:10.1111/j.1600-6135.2004.00396.x
62. Desch AN, Gibbings SL, Goyal R, Kolde R, Bednarek J, Bruno T, et al. Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med (2016) 193(6):614-26. doi:10.1164/rccm.201507-1376OC
63. Granot T, Senda T, Carpenter DJ, Matsuoka N, Weiner J, Gordon CL, et al. Dendritic cells display subset and tissue-specific maturation dynamics over human life. Immunity (2017) 46(3):504-15. doi:10.1016/j.immuni.2017.02.019
64. Rennard SI, Ghafouri M, Thompson AB, Linder J, Vaughan W, Jones K, et al. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis (1990) 141(1):208-17. doi:10.1164/ajrccm/141.1.208
65. Zavala DC. Diagnostic fiberoptic bronchoscopy: techniques and results of biopsy in 600 patients. Chest (1975) 68(1):12-9. doi:10.1378/chest.68.1.12
66. Wang KP, Mehta AC, Turner JF. Flexible Bronchoscopy. 2nd ed. Malden, MA: Blackwell Pub (2004). xi, 287 p.
67. Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ, et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci U S A (2011) 108(6):2390-5. doi:10.1073/pnas.1019682108
68. Yu CI, Becker C, Wang Y, Marches F, Helft J, Leboeuf M, et al. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-beta. Immunity (2013) 38(4):818-30. doi:10.1016/j.immuni.2013.03.004
69. Pinkerton KE, Gehr P, Castañeda A, Crapo JD. Architecture and cellular composition of the air-blood tissue barrier. In: Parent RA, editor. Comparative Biology of the Normal Lung. 2nd ed. Elsevier Inc. (2015). p. 105-17.
70. Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity (2007) 26(5):537-41. doi:10.1016/j.immuni.2007.05.001
71. Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol (2015) 16(1):27-35. doi:10.1038/ni.3045
72. McGovern N, Schlitzer A, Janela B, Ginhoux F. Protocols for the identification and isolation of antigen-presenting cells in human and mouse tissues. Methods Mol Biol (2016) 1423:169-80. doi:10.1007/978-1-4939-3606-9_12
73. Baharom F, Thomas S, Rankin G, Lepzien R, Pourazar J, Behndig AF, et al. Dendritic cells and monocytes with distinct inflammatory responses reside in lung mucosa of healthy humans. J Immunol (2016) 196(11):4498-509. doi:10.4049/jimmunol.1600071
74. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity (2012) 37(1):60-73. doi:10.1016/j.immuni.2012.04.012
75. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity (2013) 38(5):970-83. doi:10.1016/j.immuni.2013.04.011
76. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood (2001) 97(11):3470-7. doi:10.1182/blood.V97.11.3470
77. Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, et al. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood (2013) 122(6):932-42. doi:10.1182/blood-2013-04-495424
78. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med (2012) 209(4):653-60. doi:10.1084/jem.20111457
79. Haniffa M, Bigley V, Collin M. Human mononuclear phagocyte system reunited. Semin Cell Dev Biol (2015) 41:59-69. doi:10.1016/j.semcdb.2015.05.004
80. Haniffa M, Gunawan M, Jardine L. Human skin dendritic cells in health and disease. J Dermatol Sci (2015) 77(2):85-92. doi:10.1016/j.jdermsci.2014.08.012
81. Guilliams M, Dutertre C, Scott CL, McGovern N, Sichien D, Chakarov S, et al. Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species. Cell (2016) 45(3):669-84. doi:10.1016/j.immuni.2016.08.015
82. Hunninghake GW, Gadek JE, Szapiel SV, Strumpf IJ, Kawanami O, Ferrans VJ, et al. The human alveolar macrophage. In: Lecuit T, editor. Methods in Cell Biology. (Vol. 21), New York: Academic Press (1980). p. 95-112.
83. Green GM. The J. Burns Amberson Lecture - in defense of the lung. Am Rev Respir Dis (1970) 102(5):691-703. doi:10.1164/arrd.1970.102.5.691
84. Schoch OD, Schanz U, Koller M, Nakata K, Seymour JF, Russi EW, et al. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Thorax (2002) 57(3):277-80. doi:10.1136/thorax.57.3.277
85. Greenhill SR, Kotton DN. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Chest (2009) 136(2):571-7. doi:10.1378/chest.08-2943
86. Golde DW, Byers LA, Finley TN. Proliferative capacity of human alveolar macrophage. Nature (1974) 247(5440):373-5. doi:10.1038/247373a0
87. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 192(4243):1016-8. doi:10.1126/science.775638
88. Eguiluz-Gracia I, Schultz HH, Sikkeland LI, Danilova E, Holm AM, Pronk CJ, et al. Long-term persistence of human donor alveolar macrophages in lung transplant recipients. Thorax (2016) 71(11):1006-11. doi:10.1136/thoraxjnl-2016-208292
89. Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Hachem R, et al. Long-term persistence of donor alveolar macrophages in human lung transplant recipients that influences donor-specific immune responses. Am J Transplant (2016) 16(8):2300-11. doi:10.1111/ajt.13819
90. Nicod LP, Lipscomb MF, Toews GB, Weissler JC. Separation of potent and poorly functional human lung accessory cells based on autofluorescence. J Leukoc Biol (1989) 45(5):458-65.
91. van Haarst JM, de Wit HJ, Drexhage HA, Hoogsteden HC. Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in the human lung. Am J Respir Cell Mol Biol (1994) 10(5):487-92. doi:10.1165/ajrcmb.10.5.8179911
92. Ballinger MN, Christman JW. Pulmonary macrophages: overlooked and underappreciated. Am J Respir Cell Mol Biol (2016) 54(1):1-2. doi:10.1165/rcmb.2015-0270ED
93. Yu YA, Hotten DF, Malakhau Y, Volker E, Ghio AJ, Noble PW, et al. Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues. Am J Respir Cell Mol Biol (2016) 54(1):13-24. doi:10.1165/rcmb.2015-0146OC
94. Bharat A, Bhorade SM, Morales-Nebreda L, McQuattie-Pimentel AC, Soberanes S, Ridge K, et al. Flow cytometry reveals similarities between lung macrophages in humans and mice. Am J Respir Cell Mol Biol (2016) 54(1):147-9. doi:10.1165/rcmb.2015-0147LE
95. Patel VI, Booth JL, Duggan ES, Cate S, White VL, Hutchings D, et al. Transcriptional classification and functional characterization of human airway macrophage and dendritic cell subsets. J Immunol (2017) 198(3):1183-201. doi:10.4049/jimmunol.1600777
96. Toews GB, Vial WC, Dunn MM, Guzzetta P, Nunez G, Stastny P, et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 132(1):181-6.
97. Lipscomb MF, Lyons CR, Nunez G, Ball EJ, Stastny P, Vial W, et al. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol (1986) 136(2):497-504.
98. Weissler JC, Lyons CR, Lipscomb MF, Toews GB. Human pulmonary macrophages. Functional comparison of cells obtained from whole lung and by bronchoalveolar lavage. Am Rev Respir Dis (1986) 133(3):473-7. doi:10.1164/arrd.1986.133.3.473
99. Roth MD, Golub SH. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta 1 to suppress lymphocyte activation. J Leukoc Biol (1993) 53(4):366-71.
100. Blumenthal RL, Campbell DE, Hwang P, DeKruyff RH, Frankel LR, Umetsu DT. Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J Allergy Clin Immunol (2001) 107(2):258-64. doi:10.1067/mai.2001.112845
101. Lambrecht BN. Alveolar macrophage in the driver's seat. Immunity (2006) 24(4):366-8. doi:10.1016/j.immuni.2006.03.008
102. Hunninghake GW, Gadek JE, Fales HM, Crystal RG. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 66(3):473-83. doi:10.1172/JCI109878
103. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res (1991) 17(1):17-23. doi:10.3109/01902149109063278
104. Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M, et al. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol (1990) 2(4):321-6. doi:10.1165/ajrcmb/2.4.321
105. Pinilla-Vera M, Xiong Z, Zhao Y, Zhao J, Donahoe MP, Barge S, et al. Full spectrum of LPS activation in alveolar macrophages of healthy volunteers by whole transcriptomic profiling. PLoS One (2016) 11(7):e0159329. doi:10.1371/journal.pone.0159329
106. Fokkens WJ, Vroom TM, Rijntjes E, Mulder PG. CD-1 (T6), HLA-DR-expressing cells, presumably Langerhans cells, in nasal mucosa. Allergy (1989) 44(3):167-72. doi:10.1111/j.1398-9995.1989.tb02257.x
107. Graeme-Cook F, Bhan AK, Harris NL. Immunohistochemical characterization of intraepithelial and subepithelial mononuclear cells of the upper airways. Am J Pathol (1993) 143(5):1416-22.
108. Nelson DJ, McMenamin C, McWilliam AS, Brenan M, Holt PG. Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: differential regulation of Ia expression at different levels of the respiratory tract. J Exp Med (1994) 179(1):203-12. doi:10.1084/jem.179.1.203
109. Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG. Ia-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin Exp Allergy (1989) 19(6):597-601. doi:10.1111/j.1365-2222.1989.tb02752.x
110. Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, Hance AJ, Soler P. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest (1993) 91(2):566-76. doi:10.1172/JCI116236
111. Nicod LP, Lipscomb MF, Weissler JC, Lyons CR, Albertson J, Toews GB. Mononuclear cells in human lung parenchyma. Characterization of a potent accessory cell not obtained by bronchoalveolar lavage. Am Rev Respir Dis (1987) 136(4):818-23. doi:10.1164/ajrccm/136.4.818
112. Nicod LP, Galve-de Rochemonteix B, Dayer JM. Dissociation between allogeneic T cell stimulation and interleukin-1 or tumor necrosis factor production by human lung dendritic cells. Am J Respir Cell Mol Biol (1990) 2(6):515-22. doi:10.1165/ajrcmb/2.6.515
113. Streck RJ, Jezewski HM, Rodriguez MI, Hurley EL, Rich GA, Braun KM, et al. A method for isolating human lung macrophages and observations of fluorescent phagocytes from the lungs of habitual cigarette smokers. J Immunol Methods (1994) 174(1-2):67-82. doi:10.1016/0022-1759(94)90011-6
114. Cochand L, Isler P, Songeon F, Nicod LP. Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am J Respir Cell Mol Biol (1999) 21(5):547-54. doi:10.1165/ajrcmb.21.5.3785
115. van Haarst JM, Hoogsteden HC, de Wit HJ, Verhoeven GT, Havenith CE, Drexhage HA. Dendritic cells and their precursors isolated from human bronchoalveolar lavage: immunocytologic and functional properties. Am J Respir Cell Mol Biol (1994) 11(3):344-50. doi:10.1165/ajrcmb.11.3.8086170
116. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 165(11):6037-46. doi:10.4049/jimmunol.165.11.6037
117. Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol (2005) 32(3):177-84. doi:10.1165/rcmb.2004-0279OC
118. Masten BJ, Olson GK, Tarleton CA, Rund C, Schuyler M, Mehran R, et al. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J Immunol (2006) 177(11):7784-93. doi:10.4049/jimmunol.177.11.7784
119. Ten Berge B, Muskens F, Kleinjan A, Hammad H, Hoogsteden HC, Lambrecht BN, et al. A novel method for isolating dendritic cells from human bronchoalveolar lavage fluid. J Immunol Methods (2009) 351(1-2):13-23. doi:10.1016/j.jim.2009.09.009
120. Tsoumakidou M, Tzanakis N, Papadaki HA, Koutala H, Siafakas NM. Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 84(3):267-73. doi:10.1111/j.1440-1711.2006.01428.x
121. Lee H, Ruane D, Law K, Ho Y, Garg A, Rahman A, et al. Phenotype and function of nasal dendritic cells. Mucosal Immunol (2015) 8(5):1083-98. doi:10.1038/mi.2014.135
122. Baharom F, Rankin G, Scholz S, Pourazar J, Ahlm C, Blomberg A, et al. Human lung dendritic cells: spatial distribution and phenotypic identification in endobronchial biopsies using immunohistochemistry and flow cytometry. J Vis Exp (2017) (119). doi:10.3791/55222
123. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol (2015) 97(4):627-34. doi:10.1189/jlb.1HI0714-351R
124. Breton G, Zheng S, Valieris R, Tojal da Silva I, Satija R, Nussenzweig MC. Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs. J Exp Med (2016) 213(13):2861-70. doi:10.1084/jem.20161135
125. Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Respir Cell Mol Biol (2006) 35(3):387-93. doi:10.1165/rcmb.2005-0382OC
126. Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol (2013) 190(1):66-79. doi:10.4049/jimmunol.1200779
127. Yu CI, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol (2014) 193(9):4335-43. doi:10.4049/jimmunol.1401159
128. McGovern N, Schlitzer A, Gunawan M, Jardine L, Shin A, Poyner E, et al. Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages. Immunity (2014) 41(3):465-77. doi:10.1016/j.immuni.2014.08.006
129. Fathi M, Johansson A, Lundborg M, Orre L, Skold CM, Camner P. Functional and morphological differences between human alveolar and interstitial macrophages. Exp Mol Pathol (2001) 70(2):77-82. doi:10.1006/exmp.2000.2344
130. Cai Y, Sugimoto C, Arainga M, Alvarez X, Didier ES, Kuroda MJ. In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: implications for understanding lung disease in humans. J Immunol (2014) 192(6):2821-9. doi:10.4049/jimmunol.1302269
131. Misharin AV, Morales-Nebreda L, Mutlu GM, Budinger GR, Perlman H. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am J Respir Cell Mol Biol (2013) 49(4):503-10. doi:10.1165/rcmb.2013-0086MA
132. Wallis A, Spinks K. The diagnosis and management of interstitial lung diseases. BMJ (2015) 350:h2072. doi:10.1136/bmj.h2072
133. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, Kioumis I, Pitsiou G, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis (2014) 6(Suppl 1):S146-51. doi:10.3978/j.issn.2072-1439.2014.03.04
134. Aaron SD. Management and prevention of exacerbations of COPD. BMJ (2014) 349:g5237. doi:10.1136/bmj.g5237
135. Thomassen MJ, Barna BP, Wiedemann HP, Farmer M, Ahmad M. Human alveolar macrophage function: differences between smokers and nonsmokers. J Leukoc Biol (1988) 44(5):313-8.
136. King TE Jr, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis (1988) 158(6):1309-16. doi:10.1093/infdis/158.6.1309
137. Rodriguez RJ, White RR, Senior RM, Levine EA. Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers. Science (1977) 198(4314):313-4. doi:10.1126/science.910131
138. Hinman LM, Stevens CA, Matthay RA, Gee JB. Elastase and lysozyme activities in human alveolar macrophages. Effects of cigarette smoking. Am Rev Respir Dis (1980) 121(2):263-71. doi:10.1164/arrd.1980.121.2.263
139. Brown GP, Iwamoto GK, Monick MM, Hunninghake GW. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol (1989) 256(2 Pt 1):C260-4.
140. Hinman LM, Stevens C, Matthay RA, Bernard J, Gee L. Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science (1979) 205(4402):202-3. doi:10.1126/science.221980
141. Pratt SA, Finley TN, Smith MH, Ladman AJ. A comparison of alveolar macrophages and pulmonary surfactant(?) obtained from the lungs of human smokers and nonsmokers by endobronchial lavage. Anat Rec (1969) 163(4):497-507. doi:10.1002/ar.1091630402
142. Harris JO, Swenson EW, Johnson JE III. Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest (1970) 49(11):2086-96. doi:10.1172/JCI106426
143. Hoidal JR, Fox RB, LeMarbe PA, Perri R, Repine JE. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am Rev Respir Dis (1981) 123(1):85-9. doi:10.1164/arrd.1981.123.1.85
144. Karavitis J, Kovacs EJ. Macrophage phagocytosis: effects of environmental pollutants, alcohol, cigarette smoke, and other external factors. J Leukoc Biol (2011) 90(6):1065-78. doi:10.1189/jlb.0311114
145. Lee JS. Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease. J Innate Immun (2012) 4(5-6):489-97. doi:10.1159/000337434
146. Hassett DJ, Borchers MT, Panos RJ. Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives. J Microbiol (2014) 52(3):211-26. doi:10.1007/s12275-014-4068-2
147. Upham JW, Xi Y. Dendritic cells in human lung disease: recent advances. Chest (2017) 151(3):668-73. doi:10.1016/j.chest.2016.09.030
148. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 350(26):2645-53. doi:10.1056/NEJMoa032158
149. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev (2007) 87(3):1047-82. doi:10.1152/physrev.00048.2006
150. Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 175(9):926-34. doi:10.1164/rccm.200607-995OC
151. Berenson CS, Kruzel RL, Eberhardt E, Dolnick R, Minderman H, Wallace PK, et al. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations. Thorax (2014) 69(9):811-8. doi:10.1136/thoraxjnl-2013-203669
152. Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 175(10):998-1005. doi:10.1164/rccm.200608-1113OC
153. Vassallo R, Walters PR, Lamont J, Kottom TJ, Yi ES, Limper AH. Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium Study. Respir Res (2010) 11:45. doi:10.1186/1465-9921-11-45
154. Freeman CM, Martinez FJ, Han MK, Ames TM, Chensue SW, Todt JC, et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 180(12):1179-88. doi:10.1164/rccm.200904-0552OC
155. Kheradmand F, Shan M, Corry DB. Smoking gun: mature dendritic cells in human lung provide clues to chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 180(12):1166-7. doi:10.1164/rccm.200909-1391ED
156. Zanini A, Spanevello A, Baraldo S, Majori M, Della Patrona S, Gumiero F, et al. Decreased maturation of dendritic cells in the central airways of COPD patients is associated with VEGF, TGF-beta and vascularity. Respiration (2014) 87(3):234-42. doi:10.1159/000356749
157. Arellano-Orden E, Calero-Acuna C, Moreno-Mata N, Gomez-Izquierdo L, Sanchez-Lopez V, Lopez-Ramirez C, et al. Cigarette smoke decreases the maturation of lung myeloid dendritic cells. PLoS One (2016) 11(4):e0152737. doi:10.1371/journal.pone.0152737
158. Tsoumakidou M, Tousa S, Semitekolou M, Panagiotou P, Panagiotou A, Morianos I, et al. Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand. J Allergy Clin Immunol (2014) 134(4):944-54.e8. doi:10.1016/j.jaci.2014.05.045
159. Hoffmann F, Ender F, Schmudde I, Lewkowich IP, Kohl J, Konig P, et al. Origin, localization, and immunoregulatory properties of pulmonary phagocytes in allergic asthma. Front Immunol (2016) 7:107. doi:10.3389/fimmu.2016.00107
160. Hrusch CL, Tjota MY, Sperling AI. The role of dendritic cells and monocytes in the maintenance and loss of respiratory tolerance. Curr Allergy Asthma Rep (2015) 15(1):494. doi:10.1007/s11882-014-0494-9
161. Froidure A, Shen C, Pilette C. Dendritic cells revisited in human allergic rhinitis and asthma. Allergy (2016) 71(2):137-48. doi:10.1111/all.12770
162. Lambrecht BN, Persson EK, Hammad H. Myeloid cells in asthma. Microbiol Spectr (2017) 5(1):739-57. doi:10.1128/microbiolspec.MCHD-0053-2016
163. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest (2000) 106(4):551-9. doi:10.1172/JCI8107
164. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens EP, Mulder PG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy (1996) 26(5):517-24. doi:10.1046/j.1365-2222.1996.d01-337.x
165. Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax (2001) 56(11):823-6. doi:10.1136/thorax.56.11.823
166. Upham JW, Denburg JA, O'Byrne PM. Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy (2002) 32(6):818-23. doi:10.1046/j.1365-2222.2002.01375.x
167. Brugha R, Mushtaq N, McCarthy NE, Stagg AJ, Grigg J. Respiratory tract dendritic cells in paediatric asthma. Clin Exp Allergy (2015) 45(3):624-31. doi:10.1111/cea.12457
168. Bratke K, Lommatzsch M, Julius P, Kuepper M, Kleine HD, Luttmann W, et al. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax (2007) 62(2):168-75. doi:10.1136/thx.2006.067793
169. Greer AM, Matthay MA, Kukreja J, Bhakta NR, Nguyen CP, Wolters PJ, et al. Accumulation of BDCA1(+) dendritic cells in interstitial fibrotic lung diseases and Th2-high asthma. PLoS One (2014) 9(6):e99084. doi:10.1371/journal.pone.0099084
170. Lambrecht BN, Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol (2003) 3(12):994-1003. doi:10.1038/nri1249
171. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol (2015) 16(1):45-56. doi:10.1038/ni.3049
172. Mautino G, Henriquet C, Gougat C, Le Cam A, Dayer JM, Bousquet J, et al. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest (1999) 79(1):39-47.
173. Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanovic R. Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. J Allergy Clin Immunol (2012) 130(6):1404-12.e7. doi:10.1016/j.jaci.2012.07.023
174. Carmona EM, Kalra S, Ryu JH. Pulmonary sarcoidosis: diagnosis and treatment. Mayo Clin Proc (2016) 91(7):946-54. doi:10.1016/j.mayocp.2016.03.004
175. Terao I, Hashimoto S, Horie T. Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis. Int Arch Allergy Immunol (1993) 102(3):242-8. doi:10.1159/000236532
176. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Muller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med (1997) 156(5):1586-92. doi:10.1164/ajrccm.156.5.97-02050
177. Betensley A, Sharif R, Karamichos D. A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis. J Clin Med (2016) 6(1):2. doi:10.3390/jcm6010002
178. Rennard SI, Hunninghake GW, Bitterman PB, Crystal RG. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 78(11):7147-51. doi:10.1073/pnas.78.11.7147
179. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, Goldmann T, et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med (2006) 173(7):781-92. doi:10.1164/rccm.200509-1518OC
180. Tsoumakidou M, Karagiannis KP, Bouloukaki I, Zakynthinos S, Tzanakis N, Siafakas NM. Increased bronchoalveolar lavage fluid CD1c expressing dendritic cells in idiopathic pulmonary fibrosis. Respiration (2009) 78(4):446-52. doi:10.1159/000226244
181. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, Kambouchner M, Valeyre D, Crestani B, et al. Dendritic cells accumulate in human fibrotic interstitial lung disease. Am J Respir Crit Care Med (2007) 176(10):1007-14. doi:10.1164/rccm.200609-1347OC
182. Lommatzsch M, Bratke K, Bier A, Julius P, Kuepper M, Luttmann W, et al. Airway dendritic cell phenotypes in inflammatory diseases of the human lung. Eur Respir J (2007) 30(5):878-86. doi:10.1183/09031936.00036307
183. Spiteri MA, Clarke SW, Poulter LW. Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (1988) 74(3):359-64.
184. Krombach F, Gerlach JT, Padovan C, Burges A, Behr J, Beinert T, et al. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J (1996) 9(5):984-91. doi:10.1183/09031936.96.09050984
185. Zaba LC, Smith GP, Sanchez M, Prystowsky SD. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol (2010) 42(1):32-9. doi:10.1165/rcmb.2009-0033TR
186. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, Valeyre D, Soumelis V, Crestani B, et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol (2006) 176(10):5735-9. doi:10.4049/jimmunol.176.10.5735
187. Freynet O, Marchal-Somme J, Jean-Louis F, Mailleux A, Crestani B, Soler P, et al. Human lung fibroblasts may modulate dendritic cell phenotype and function: results from a pilot in vitro study. Respir Res (2016) 17:36. doi:10.1186/s12931-016-0345-4
188. Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J Clin Invest (1994) 94(4):1533-42. doi:10.1172/JCI117494
189. Mathew S, Bauer KL, Fischoeder A, Bhardwaj N, Oliver SJ. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol (2008) 181(1):746-55. doi:10.4049/jimmunol.181.1.746
190. Broos CE, van Nimwegen M, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Granuloma formation in pulmonary sarcoidosis. Front Immunol (2013) 4:437. doi:10.3389/fimmu.2013.00437
191. Sasindran SJ, Torrelles JB. Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium? Front Microbiol (2011) 2:2. doi:10.3389/fmicb.2011.00002
192. Engele M, Stossel E, Castiglione K, Schwerdtner N, Wagner M, Bolcskei P, et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immunol (2002) 168(3):1328-37. doi:10.4049/jimmunol.168.3.1328
193. Buettner M, Meinken C, Bastian M, Bhat R, Stossel E, Faller G, et al. Inverse correlation of maturity and antibacterial activity in human dendritic cells. J Immunol (2005) 174(7):4203-9. doi:10.4049/jimmunol.174.7.4203
194. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 12(10):1203-7. doi:10.1038/nm1477
195. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 101(3):643-9. doi:10.1172/JCI1355
196. Jorens PG, Van Damme J, De Backer W, Bossaert L, De Jongh RF, Herman AG, et al. Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine (1992) 4(6):592-7. doi:10.1016/1043-4666(92)90025-M
197. Huang Y, Zhu W, Zeng X, Li S, Li X, Lu C. Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09. Arch Virol (2013) 158(11):2267-72. doi:10.1007/s00705-013-1692-9
198. Gill MA, Palucka AK, Barton T, Ghaffar F, Jafri H, Banchereau J, et al. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis (2005) 191(7):1105-15. doi:10.1086/428589
199. Gill MA, Long K, Kwon T, Muniz L, Mejias A, Connolly J, et al. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis (2008) 198(11):1667-76. doi:10.1086/593018
200. Oshansky CM, Gartland AJ, Wong SS, Jeevan T, Wang D, Roddam PL, et al. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am J Respir Crit Care Med (2014) 189(4):449-62. doi:10.1164/rccm.201309-1616OC
201. van Riel D, Leijten LM, van der Eerden M, Hoogsteden HC, Boven LA, Lambrecht BN, et al. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog (2011) 7(6):e1002099. doi:10.1371/journal.ppat.1002099
202. Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol (1991) 147(12):4307-12.
203. Remark R, Becker C, Gomez JE, Damotte D, Dieu-Nosjean MC, Sautes-Fridman C, et al. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med (2015) 191(4):377-90. doi:10.1164/rccm.201409-1671PP
204. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer (2012) 12(4):298-306. doi:10.1038/nrc3245
205. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol (2008) 26(27):4410-7. doi:10.1200/JCO.2007.15.0284
206. Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res (2014) 74(3):705-15. doi:10.1158/0008-5472.CAN-13-1342
207. Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol (2011) 28(3):682-8. doi:10.1007/s12032-010-9515-2
208. Perrot I, Blanchard D, Freymond N, Isaac S, Guibert B, Pacheco Y, et al. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J Immunol (2007) 178(5):2763-9. doi:10.4049/jimmunol.178.5.2763
209. Valecha GK, Vennepureddy A, Ibrahim U, Safa F, Samra B, Atallah JP. Anti-PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy. Expert Rev Anticancer Ther (2017) 17(1):47-59. doi:10.1080/14737140.2017.1259574
210. ImmGen C. Open-source ImmGen: mononuclear phagocytes. Nat Immunol (2016) 17(7):741. doi:10.1038/ni.3478
211. Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res (2012) 160(4):258-66. doi:10.1016/j.trsl.2012.02.005